What is the recommended frequency for administering an intramuscular (IM) Toradol (ketorolac) injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Frequency of Intramuscular Ketorolac (Toradol) Injections

Intramuscular ketorolac (Toradol) injections should not be administered more frequently than every 6 hours, with a maximum duration of 5 days total treatment. 1, 2

Dosing Guidelines

Standard Dosing

  • Adults under 65 years:
    • 30 mg IM every 6 hours
    • Maximum daily dose: 120 mg 1

Special Populations

  • Adults 65 years and older, renally impaired, or under 50 kg (110 lbs):
    • 15 mg IM every 6 hours
    • Maximum daily dose: 60 mg 1

Single-Dose Treatment

  • Adults under 65 years: One dose of 60 mg IM
  • Adults 65 years and older, renally impaired, or under 50 kg: One dose of 30 mg IM 1

Important Safety Considerations

Duration Limitations

  • Treatment with ketorolac must not exceed 5 days total duration 1, 2, 3
  • Patients should be switched to alternative analgesics as soon as possible 1

Administration Technique

  • Intramuscular injections should be given slowly and deeply into the muscle 1
  • The analgesic effect begins in approximately 30 minutes with maximum effect in 1-2 hours
  • Duration of analgesic effect is usually 4-6 hours 1

Contraindications

Ketorolac is contraindicated in patients with:

  • History of or current risk of gastrointestinal bleeding
  • Risk of renal failure
  • Compromised hemostasis
  • Hypersensitivity to aspirin or other NSAIDs
  • Pregnancy
  • Cerebrovascular hemorrhage 2

Monitoring Requirements

  • Baseline assessment recommended for:

    • Blood pressure
    • BUN and creatinine
    • Liver function tests
    • CBC and fecal occult blood 2
  • Discontinue ketorolac immediately if:

    • Renal function tests double
    • Hypertension develops or worsens
    • Liver function studies increase beyond normal limits 2

Clinical Pearls

  • For breakthrough pain, do not increase the dose or frequency of ketorolac 1
  • Consider supplementing with low doses of opioids "prn" unless otherwise contraindicated 1
  • Hypovolemia should be corrected prior to administration of ketorolac 1
  • Ketorolac should not be mixed in a small volume (e.g., in a syringe) with morphine sulfate, meperidine hydrochloride, promethazine hydrochloride, or hydroxyzine hydrochloride as this will result in precipitation 1

Remember that ketorolac is intended for short-term management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting 1. The strict adherence to dosing frequency and maximum duration limits is essential to minimize the risk of serious adverse effects.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.